{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:47:20Z","timestamp":1770497240298,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T00:00:00Z","timestamp":1183075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2458-7-130","type":"journal-article","created":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T18:12:56Z","timestamp":1183140776000},"source":"Crossref","is-referenced-by-count":19,"title":["Invasive meningococcal disease epidemiology and control measures: a framework for evaluation"],"prefix":"10.1186","volume":"7","author":[{"given":"J Jaime","family":"Caro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Getsios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Coudeville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam","family":"El-Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Chevat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Hung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,29]]},"reference":[{"key":"741_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM: Meningococcal disease. N Engl J Med. 2001, 344: 1378-1388. 10.1056\/NEJM200105033441807.","journal-title":"N Engl J Med"},{"key":"741_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10096-004-1159-8","volume":"23","author":"H Jaccard Ruedin","year":"2004","unstructured":"Jaccard Ruedin H, Ninet B, Pagano E, Rohner P: Epidemiology of meningococcal disease in Switzerland, 1999\u20132002. Eur J Clin Microbiol Infect Dis. 2004, 23: 517-522. 10.1007\/s10096-004-1159-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1086\/520303","volume":"26","author":"L Erickson","year":"1998","unstructured":"Erickson L, De Wals P: Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994. Clin Infect Dis. 1998, 26: 1164-10.1086\/520303.","journal-title":"Clin Infect Dis"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1086\/340050","volume":"34","author":"CM Healy","year":"2002","unstructured":"Healy CM, Butler KM, Smith EO, Hensey OP, Bate T, Moloney AC, MacMahon P, Cosgrove J, Cafferkey MT: Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995\u20132000. Clin Infect Dis. 2002, 34: 1323-1330. 10.1086\/340050.","journal-title":"Clin Infect Dis"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/322587","volume":"33","author":"LJ Erickson","year":"2001","unstructured":"Erickson LJ, De Wals P, McMahon J, Heim S: Complications of meningococcal disease in college students. Clin Infect Dis. 2001, 33: 737-739. 10.1086\/322587.","journal-title":"Clin Infect Dis"},{"key":"741_CR6","unstructured":"Brooks RB, Woods CW, Rosenstein NE: Neisseria meningitidis outbreaks in the United States, 1994\u20132002. [Abstract] 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9\u201312, 2003"},{"key":"741_CR7","first-page":"13","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","unstructured":"Centers for Disease Control and Prevention: Prevention and control of meningococcal disease and meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000, 49: 13-20.","journal-title":"MMWR"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1517\/14656566.5.4.855","volume":"5","author":"SZ Zimmer","year":"2004","unstructured":"Zimmer SZ, Stephens DS: Meningococcal conjugate vaccines. Expert Opin Pharmacother. 2004, 5: 855-863. 10.1517\/14656566.5.4.855.","journal-title":"Expert Opin Pharmacother"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"N821","DOI":"10.1099\/jmm.0.45529-0","volume":"53","author":"SP Yazdankhah","year":"2004","unstructured":"Yazdankhah SP, Caugant DA: eisseria meningitidis: an overview of the carriage state. Journal of Medical Microbiology. 2004, 53: N821-832. 10.1099\/jmm.0.45529-0.","journal-title":"Journal of Medical Microbiology"},{"key":"741_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","volume":"359","author":"MCJ Maiden","year":"2002","unstructured":"Maiden MCJ, Stuart JM, for the UK Meningococcal Carriage Group: Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002, 359: 1829-1830. 10.1016\/S0140-6736(02)08679-8.","journal-title":"Lancet"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","volume":"326","author":"ME Ramsay","year":"2003","unstructured":"Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E: Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ. 2003, 326: 365-366. 10.1136\/bmj.326.7385.365.","journal-title":"BMJ"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"CL Trotter","year":"2004","unstructured":"Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME: Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004, 364: 365-367. 10.1016\/S0140-6736(04)16725-1.","journal-title":"Lancet"},{"key":"741_CR13","first-page":"1","volume":"54","author":"OO Bilukha","year":"2005","unstructured":"Bilukha OO, Rosenstein N: Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005, 54: 1-21.","journal-title":"MMWR Recomm Rep"},{"key":"741_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1017\/S0266462304001096","volume":"20","author":"D Getsios","year":"2004","unstructured":"Getsios D, Caro I, El-Hadi W, Caro JJ: Assessing the economics of vaccination for neisseria meningitidis in industrialized nations: a review and recommendations for further research. Int J Technol Assess Health Care. 2004, 20: 280-288.","journal-title":"Int J Technol Assess Health Care"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.vaccine.2004.06.019","volume":"23","author":"R Welte","year":"2004","unstructured":"Welte R, van den Dobbelsteen G, Bos JM, de Melker H, van Alphen L, Spanjaard L, Rumke HC, Postma MJ: Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine. 2004, 23: 470-479. 10.1016\/j.vaccine.2004.06.019.","journal-title":"Vaccine"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1016\/S0264-410X(03)00562-0","volume":"21","author":"H Jaccard Ruedin","year":"2003","unstructured":"Jaccard Ruedin H, Ess S, Zimmermann HP, Szucs T: Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccination strategies. Vaccine. 2003, 21: 4145-4152. 10.1016\/S0264-410X(03)00562-0.","journal-title":"Vaccine"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S0950268803008501","volume":"130","author":"HC Tuckwell","year":"2003","unstructured":"Tuckwell HC, Hanslik T, Valleron A-J, Flahault A: A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis. Epidemiol Infect. 2003, 130: 419-429.","journal-title":"Epidemiol Infect"},{"key":"741_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/sim.1666","volume":"23","author":"J Ranta","year":"2004","unstructured":"Ranta J, M\u00e4kel\u00e4 PH, Arjas E: Predicting meningococcal disease outbreaks in structured populations. Stat Med. 2004, 23: 927-945. 10.1002\/sim.1666.","journal-title":"Stat Med"},{"key":"741_CR19","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1542\/peds.2004-2514","volume":"115","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Ismael R, Ortega-Sanchez R, Scott RD, Rosenstein NE, the ABCs Team: Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics. 2005, 115: 1220-1232. 10.1542\/peds.2004-2514.","journal-title":"Pediatrics"},{"key":"741_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/aje\/kwi160","volume":"162","author":"CL Trotter","year":"2005","unstructured":"Trotter CL, Gay NJ, Edmunds WJ: Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol. 2005, 162: 89-100. 10.1093\/aje\/kwi160.","journal-title":"Am J Epidemiol"},{"key":"741_CR21","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1073\/pnas.0400695101","volume":"101","author":"N Stollenwerk","year":"2004","unstructured":"Stollenwerk N, Maiden MCJ, Jansen VAA: Diversity in pathogencity can cause outbreaks of meningococcal disease. PNAS. 2004, 101: 10229-10234. 10.1073\/pnas.0400695101.","journal-title":"PNAS"},{"key":"741_CR22","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1016\/j.vaccine.2006.02.010","volume":"24","author":"P De Wals","year":"2006","unstructured":"De Wals P, Trottier P, P\u00e9pin J: Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation. Vaccine. 2006, 24: 3500-3504. 10.1016\/j.vaccine.2006.02.010.","journal-title":"Vaccine"},{"key":"741_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0272989X05284109","volume":"26","author":"CL Trotter","year":"2006","unstructured":"Trotter CL, Edmunds WJ: Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making. 2006, 26: 38-47. 10.1177\/0272989X05284109.","journal-title":"Med Decis Making"},{"key":"741_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00019053-200523040-00003","volume":"23","author":"JJ Caro","year":"2005","unstructured":"Caro JJ: Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics. 2005, 23: 323-332. 10.2165\/00019053-200523040-00003.","journal-title":"Pharmacoeconomics"},{"key":"741_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.publhealth.25.102802.124353","volume":"25","author":"J Koopman","year":"2004","unstructured":"Koopman J: Modeling infection transmission. Annu Rev Public Health. 2004, 25: 303-326. 10.1146\/annurev.publhealth.25.102802.124353.","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"741_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2105\/AJPH.85.6.843","volume":"85","author":"LA Jackson","year":"1995","unstructured":"Jackson LA, Schuchat A, Gorsky RD, Wenger JD: Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J of Public Health. 1995, 85 (6): 843-845.","journal-title":"Am J of Public Health"},{"issue":"2","key":"741_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0749-3797(02)00462-2","volume":"23","author":"RD Scott II","year":"2002","unstructured":"Scott RD, Meltzer MI, Erickson LJ, De Wals P, Rosenstein NE: Vaccinating first-year college students living in dormitories for meningococcal disease. An economic analysis. Am J Prev Med. 2002, 23 (2): 98-105. 10.1016\/S0749-3797(02)00462-2.","journal-title":"Am J Prev Med"},{"key":"741_CR28","first-page":"R195","volume":"7","author":"L Hastings","year":"1997","unstructured":"Hastings L, Stuart J, Andrews N, Begg N: A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep. 1997, 7: R195-R200.","journal-title":"Commun Dis Rep"},{"key":"741_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jama.1997.03540290041030","volume":"277","author":"KM Zangwill","year":"1997","unstructured":"Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW, Wenger JD: School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. JAMA. 1997, 277: 389-395. 10.1001\/jama.277.5.389.","journal-title":"JAMA"},{"key":"741_CR30","first-page":"1","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention: Control and prevention of serogroup C meningococcal: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997, 46: 1-21.","journal-title":"MMWR"},{"key":"741_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1086\/378743","volume":"37","author":"DM Patrick","year":"2003","unstructured":"Patrick DM, Champagne S, Goh SH, Arsenault G, Thomas E, Shaw C, Rahim T, Taha F, Bigham M, Dubenko V, Skowronski D, Brunham RC: Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin Infect Dis. 2003, 37: 1183-1188. 10.1086\/378743.","journal-title":"Clin Infect Dis"},{"key":"741_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/341067","volume":"186","author":"SE Kellerman","year":"2002","unstructured":"Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T, Rosenstein NE, Farley MM, Blake P, Stephens DS, Georgia Emerging Infections Program: Genotype-specific carriage of neisseria meningitidis in Georgia counties with hyper-and hyposporadic rates of meningococcal disease. J Infect Dis. 2002, 186: 40-48. 10.1086\/341067.","journal-title":"J Infect Dis"},{"key":"741_CR33","first-page":"407","volume":"74","author":"P De Wals","year":"1996","unstructured":"De Wals P, Dionne M, Douville-Fradet M, Boulianne N, Drapeau J, De Serres G: Impact of mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada. WHO Bulletin OMS. 1996, 74: 407-411.","journal-title":"WHO Bulletin OMS"},{"key":"741_CR34","first-page":"220","volume":"5","author":"CL Trotter","year":"2002","unstructured":"Trotter CL, Ramsay ME, Kaczmarski EB: Meningococcal serougroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health. 2002, 5: 220-225.","journal-title":"Commun Dis Public Health"},{"key":"741_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMsa025075","volume":"3","author":"SA Bozzette","year":"2003","unstructured":"Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton Stoto MA: A model for a smallpox-vaccination policy. N Engl J Med. 2003, 3: 416-425. 10.1056\/NEJMsa025075.","journal-title":"N Engl J Med"},{"key":"741_CR36","unstructured":"National Center for Education Statistics: Digest of education statistics tables and figures 2001. Accessed June 16, 2003, [ http:\/\/nces.ed.gov\/programs\/digest\/d01\/index.asp ]"},{"key":"741_CR37","unstructured":"National Center for Education Statistics: Student effort and educational progress 2003. [ http:\/\/nces.ed.gov\/pubs2003\/2003067_3.pdf ]"},{"key":"741_CR38","unstructured":"Centers for Disease Control and Prevention: Active Bacterial Core Surveillance Reports, 1997\u20132001. [ http:\/\/www.cdc.gov\/abcs ]"},{"key":"741_CR39","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1086\/315158","volume":"180","author":"NE Rosenstein","year":"1999","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL: The changing epidemiology of meningococcal disease in the United States, 1992\u20131996. J Infect Dis. 1999, 180: 1894-1901. 10.1086\/315158.","journal-title":"J Infect Dis"},{"key":"741_CR40","first-page":"177","volume":"26","author":"SG Squires","year":"2000","unstructured":"Squires SG, Pelletier L, Mungai M, Tsang R, Collins F, Stoltz J: Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998. Can Commun Dis Rep. 2000, 26: 177-182.","journal-title":"Can Commun Dis Rep"},{"key":"741_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3201\/eid0903.020071","volume":"9","author":"A Sampaio Moura","year":"2003","unstructured":"Sampaio Moura A, Pablos-Mendez A, Layton M, Weiss D: Epidemiology of meningococcal disease, New York City, 1989\u20132000. Emerg Infect Dis. 2003, 9: 355-361.","journal-title":"Emerg Infect Dis"},{"key":"741_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00006454-200205000-00003","volume":"21","author":"SH Stovall","year":"2002","unstructured":"Stovall SH, Schutz GE: Meningococcal infections in children in Arkansas. Pediatr Infect Dis J. 2002, 21: 366-370. 10.1097\/00006454-200205000-00003.","journal-title":"Pediatr Infect Dis J"},{"key":"741_CR43","volume-title":"Comparative review and assessment of key health state measures of the general population","author":"P Sturgis","year":"2001","unstructured":"Sturgis P, Thomas R, Purdon S, Bridgewood A, Dodd T: Comparative review and assessment of key health state measures of the general population. 2001, Department of Health, London"},{"key":"741_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0264-410X(01)00254-7","volume":"20","author":"JM Bos","year":"2002","unstructured":"Bos JM, Rumke HC, Welte R, Postma MJ, Jager JC: Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program. Vaccine. 2002, 20: 202-207. 10.1016\/S0264-410X(01)00254-7.","journal-title":"Vaccine"},{"key":"741_CR45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0895-4356(02)00448-1","volume":"55","author":"R Oostenbrink","year":"2002","unstructured":"Oostenbrink R, Moll HA, Essink-Bot M: The EQ-5D and the health utilities index for permanent sequelae after meningitis. A head-to-head comparison. J Clin Epidemiol. 2002, 55: 791-799. 10.1016\/S0895-4356(02)00448-1.","journal-title":"J Clin Epidemiol"},{"key":"741_CR46","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jama.1996.03540170053032","volume":"276","author":"The Diabetes Control and Complications Trial Research Group","year":"1996","unstructured":"The Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1996, 276: 1409-1415. 10.1001\/jama.276.17.1409.","journal-title":"JAMA"},{"key":"741_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ije\/29.1.180","volume":"29","author":"PG Coen","year":"2000","unstructured":"Coen PG, Cartwright K, Stuart J: Mathematical modelling of infection and disease due to neisseria meningitidis and neisseria lactamia. Int J Epidemiol. 2000, 29: 180-188. 10.1093\/ije\/29.1.180.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-7-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T23:13:44Z","timestamp":1556579624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-7-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-7-130","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,29]]},"article-number":"130"}}